ono-2808
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 19, 2020 (NCT04578028)
Timeline
Indications
Mechanism of action
S1PR5 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05923866 | Phase 2 | Sep 22, 2023 | Ono Pharmaceuticals |
| NCT04578028 | Phase 1 | Aug 19, 2020 | Ono Pharmaceuticals, Parexel |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 2 | 2 | 2 | 2020 |
| Parexel | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1